MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $873 | +21.2% | 20,048 | +0.6% | 0.01% | +25.0% |
| Q2 2023 | $720 | -0.7% | 19,938 | +2.2% | 0.00% | 0.0% |
| Q1 2023 | $725 | -17.4% | 19,508 | +0.7% | 0.00% | -20.0% |
| Q4 2022 | $878 | -99.9% | 19,368 | +5.0% | 0.01% | -44.4% |
| Q3 2022 | $1,288,000 | +5.4% | 18,438 | +1.3% | 0.01% | +12.5% |
| Q2 2022 | $1,222,000 | -3.6% | 18,198 | +18.0% | 0.01% | +14.3% |
| Q1 2022 | $1,268,000 | -43.1% | 15,427 | +1.6% | 0.01% | -41.7% |
| Q4 2021 | $2,227,000 | -11.0% | 15,179 | +7.4% | 0.01% | -14.3% |
| Q3 2021 | $2,501,000 | +13.4% | 14,139 | +3.5% | 0.01% | +7.7% |
| Q2 2021 | $2,206,000 | – | 13,660 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |